{
  "_id": "NCT01902602",
  "title": "Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia",
  "text": "Summary: The objective of this clinical study is to evaluate the influence of the Great autohemotherapy with oxygen-ozone (hyperbaric ozone therapy ) to describe the cardiovascular system in patients with resistant hypertension. The primary endpoint is the change in mean blood pressure after 10 treatments .~In addition, data are collected on the immune system as well as for food and sleep quality.\nInclusion criteria: inclusion criteria: \n\n Resistant Hypertension > 140 / > 90mmHg \n\n Inclusion age : 45 + \n\n Regular monitoring of blood levels considered \n\n pre-medication to lower blood pressure for at least 3 weeks before the preliminary investigation consistent \n\n Men and Women \n\n \nExclusion criteria: : \n\n derailed diabetes \n\n renal impairment , renal creatinine clear <50 ml \n\n Non - austherapierte cancer / tumor patients \n\n Non - adjusted thyroid dysfunction \n\n BMI> 35 \n\n LVEF <limit (  35%  ) \n\n Peripheral AVK ( ABI - measurement ) > Stage II \n\n regurgitation > Stage I \n\n abdominal aneurysm \n\n infections \n\n acute febrile infections with temperature > 38.5 ° C \n\n COPD and asthma to stage III \n\n dyspnea NYHA > Stage III \n\n z.n. Stroke shorter than 12 weeks \n\n Acute liver failure \n\n Acute Apoplexy \n\n Severe poisoning \n\n drug addiction \n\n hyperthyroidism \n\n Hypotension \n\n hypocalcemia \n\n hypoglycemia \n\n ozone allergy \n\n pregnancy \n\n clotting problems ( hemophilia ) \n\n pre-existing condition with hemoglobin < 9mg/dl \n\n Fresh myocardial infarction \n\n Internal bleeding \n\n thrombocytopenia \n\n Acute alcohol \n\n Citrus allergy when using sodium citrate",
  "metadata": {
    "brief_title": "Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia",
    "phase": "",
    "drugs": "",
    "drugs_list": [],
    "diseases": "['Hypertonia']",
    "diseases_list": [
      "Hypertonia"
    ],
    "enrollment": "19.0",
    "inclusion_criteria": "inclusion criteria: \n\n Resistant Hypertension > 140 / > 90mmHg \n\n Inclusion age : 45 + \n\n Regular monitoring of blood levels considered \n\n pre-medication to lower blood pressure for at least 3 weeks before the preliminary investigation consistent \n\n Men and Women \n\n ",
    "exclusion_criteria": ": \n\n derailed diabetes \n\n renal impairment , renal creatinine clear <50 ml \n\n Non - austherapierte cancer / tumor patients \n\n Non - adjusted thyroid dysfunction \n\n BMI> 35 \n\n LVEF <limit (  35%  ) \n\n Peripheral AVK ( ABI - measurement ) > Stage II \n\n regurgitation > Stage I \n\n abdominal aneurysm \n\n infections \n\n acute febrile infections with temperature > 38.5 ° C \n\n COPD and asthma to stage III \n\n dyspnea NYHA > Stage III \n\n z.n. Stroke shorter than 12 weeks \n\n Acute liver failure \n\n Acute Apoplexy \n\n Severe poisoning \n\n drug addiction \n\n hyperthyroidism \n\n Hypotension \n\n hypocalcemia \n\n hypoglycemia \n\n ozone allergy \n\n pregnancy \n\n clotting problems ( hemophilia ) \n\n pre-existing condition with hemoglobin < 9mg/dl \n\n Fresh myocardial infarction \n\n Internal bleeding \n\n thrombocytopenia \n\n Acute alcohol \n\n Citrus allergy when using sodium citrate",
    "brief_summary": "The objective of this clinical study is to evaluate the influence of the Great autohemotherapy with oxygen-ozone (hyperbaric ozone therapy ) to describe the cardiovascular system in patients with resistant hypertension. The primary endpoint is the change in mean blood pressure after 10 treatments .~In addition, data are collected on the immune system as well as for food and sleep quality."
  }
}